Lineage Cell Therapeutics Inc.

03/23/2026 | Press release | Distributed by Public on 03/24/2026 04:04

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 23, 2026 4:30 P.M.
Form: S-3
CIK: 0000876343
Company Name: Lineage Cell Therapeutics, Inc.
File Number: 333-294202
Lineage Cell Therapeutics Inc. published this content on March 23, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 24, 2026 at 10:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]